1. Yao-Jong Yang,Bor-Shyang Sheu (2016). Metabolic Interaction of Helicobacter pylori Infection and Gut Microbiota. Microorganisms, 4(1), 15.
2. Nicholas Martinez,Md Garapati,M.,Charles Randall,M. (2014). Management of Helicobacter Pylori Infection. Journal of Tropical Diseases, 02(01), 1.
3. W. Yuan,Li Yumin,Yang Kehu,Ma Bin,Guan Quanlin (2010). Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials. Scand J Gastroenterol, 45, 665-676.
4. B. Egan,M. Katicic,H. O’Connor,C. O'morain (2007). Treatment of Helicobacter pylori. Helicobacter, 12(s1), 31-37.
5. M. Janssen,L. Hendrikse,S. de Boer,R. Bosboom,W. de Boer,R. Laheij,J. Jansen (2006). Helicobacter pylori antibiotic resistance in a Dutch region: trends over time. Neth J Med, 64, 191-195.
6. M. Sharma Helicobacter pylori Eradication: Decision Making in Clinical Practice.
7. (2010). World Gastroenterology Organisation Global Guidelines Report on Helicobacter pylori in developing countries.
8. A. Olokoba,O. Obateru,M. Bojuwoye (2013). Helicobacter pylori eradication therapy: A review of current trends. Nigerian Medical Journal, 54(1), 1.
9. Zullo A,Vaira D,Vakil N,Hassan C,Gatta L,Ricci C (2003). High eradication rates of Helicobacter pylori with a new sequential treatment. Alimentary Pharmacology & Therapeutics, 17(5), 719-726.
10. Egan BJ,O’Morain CA (2007). A historical perspective of Helicobacter gastroduodenitis and its complications. Best Pract Res Clin Gastroenterol, 21, 335-346.
11. Malfertheiner P,Megraud F,O’Morain C (2007). Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut, 56, 772-781.
12. J. Chung,G. Lee,J. Han (2011). The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea. Hepatogastroenterology, 58, 246-250.
13. Jai Yoon,G. Baik,K. Sohn (2012). Trends in the eradication rates ofHelicobacter pyloriinfection for eleven years. World Journal of Gastroenterology, 18(45), 6628.
14. Jung YS,Lee SH,Park CS (2014). Trends in the Eradication Rates ofHelicobacter pylori Infection in Daegu and Gyeongsangbuk-do, Korea: Multicenter Study over 13 Years. The Korean Journal of Gastroenterology, 63(2), 82.
15. Hye Jeon,Gwang Kim (2014). Does Standard Triple Therapy Still Have a Role in First-Line Helicobacter pylori Eradication in Korea?. Journal of Korean Medical Science, 29(5), 619.
16. Gong EJ,Yun SC,Jung HY (2014). Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?. Journal of Korean Medical Science, 29(5), 704.
17. MS (2014). Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol, 12, 18.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31. Rajinikanth Siddalingam,Kumarappan Chidambaram Helicobacter pylori — Current Therapy and Future Therapeutic Strategies.
